TransMedics Group, Inc. Capital Expenditures
TransMedics Group, Inc. (TMDX) reported Capital Expenditures of $43.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $7.09M, a 21.85% decline year-over-year.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $36.66M, a 35.58% increase year-over-year.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $15.51M, a 14.02% increase year-over-year.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $7.62M, a 84.18% decline year-over-year.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $59.25M, a 54.33% decline from fiscal 2024.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $129.74M, a 14.56% decline from fiscal 2023.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $151.85M, a 1175.28% increase from fiscal 2022.
- TransMedics Group, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $11.91M, a 238.36% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $43.75M 10-Q · filed 2026-08-04 | $59.26M derived: sum of 3 quarters · filed 2026-08-04 | $66.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $36.66M 10-Q · filed 2026-05-05 | $52.17M derived: sum of 2 quarters · filed 2026-05-05 | $59.80M derived: sum of 3 quarters · filed 2026-05-05 | $68.87M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $15.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $23.14M derived: sum of 2 quarters · filed 2026-02-24 | $32.21M derived: sum of 3 quarters · filed 2026-08-04 | $59.25M 10-K · filed 2026-02-24 |
| 2025-09-30 | $7.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $16.70M derived: sum of 2 quarters · filed 2026-08-04 | $43.74M 10-Q · filed 2025-10-29 | $57.34M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $9.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $36.11M 10-Q · filed 2026-08-04 | $49.72M derived: sum of 3 quarters · filed 2026-08-04 | $97.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $27.04M 10-Q · filed 2026-05-05 | $40.64M derived: sum of 2 quarters · filed 2026-05-05 | $88.85M derived: sum of 3 quarters · filed 2026-05-05 | $112.61M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $13.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $61.81M derived: sum of 2 quarters · filed 2026-02-24 | $85.57M derived: sum of 3 quarters · filed 2026-02-24 | $129.74M 10-K · filed 2026-02-24 |
| 2024-09-30 | $48.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $71.97M derived: sum of 2 quarters · filed 2025-10-29 | $116.14M 10-Q · filed 2025-10-29 | $157.96M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $23.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $67.94M 10-Q · filed 2025-07-30 | $109.75M derived: sum of 3 quarters · filed 2026-02-24 | $217.47M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $44.17M 10-Q · filed 2025-05-08 | $85.99M derived: sum of 2 quarters · filed 2026-02-24 | $193.71M derived: sum of 3 quarters · filed 2026-02-24 | $195.09M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $41.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $149.54M derived: sum of 2 quarters · filed 2026-02-24 | $150.92M derived: sum of 3 quarters · filed 2026-02-24 | $151.85M 10-K · filed 2026-02-24 |
| 2023-09-30 | $107.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $109.10M derived: sum of 2 quarters · filed 2024-10-29 | $110.03M 10-Q · filed 2024-10-29 | $112.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.31M 10-Q · filed 2024-08-01 | $5.07M derived: sum of 3 quarters · filed 2025-02-27 | $8.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $927.00K 10-Q · filed 2024-05-02 | $3.69M derived: sum of 2 quarters · filed 2025-02-27 | $6.62M derived: sum of 3 quarters · filed 2025-02-27 | $10.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.69M derived: sum of 2 quarters · filed 2025-02-27 | $9.95M derived: sum of 3 quarters · filed 2025-02-27 | $11.91M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $7.19M derived: sum of 2 quarters · filed 2023-11-08 | $9.14M 10-Q · filed 2023-11-08 | $12.32M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $6.21M 10-Q · filed 2023-08-04 | $9.39M derived: sum of 3 quarters · filed 2024-02-27 | $9.46M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.95M 10-Q · filed 2023-05-04 | $5.13M derived: sum of 2 quarters · filed 2024-02-27 | $5.20M derived: sum of 3 quarters · filed 2024-02-27 | $5.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.25M derived: sum of 2 quarters · filed 2024-02-27 | $3.50M derived: sum of 3 quarters · filed 2024-02-27 | $3.52M 10-K · filed 2024-02-27 |
| 2021-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $321.00K derived: sum of 2 quarters · filed 2022-11-04 | $341.00K 10-Q · filed 2022-11-04 | $343.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $273.00K 10-Q · filed 2022-08-03 | $275.00K derived: sum of 3 quarters · filed 2023-02-27 | $331.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $20.00K 10-Q · filed 2022-05-05 | $22.00K derived: sum of 2 quarters · filed 2023-02-27 | $78.00K derived: sum of 3 quarters · filed 2023-02-27 | $198.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $58.00K derived: sum of 2 quarters · filed 2023-02-27 | $178.00K derived: sum of 3 quarters · filed 2023-02-27 | $455.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $176.00K derived: sum of 2 quarters · filed 2021-11-09 | $453.00K 10-Q · filed 2021-11-09 | $434.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $397.00K 10-Q · filed 2021-08-06 | $378.00K derived: sum of 3 quarters · filed 2021-05-07 | $411.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $277.00K 10-Q · filed 2021-05-07 | $258.00K derived: sum of 2 quarters · filed 2021-05-07 | $291.00K derived: sum of 3 quarters · filed 2021-05-07 | $439.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $14.00K derived: sum of 2 quarters · filed 2021-03-11 | $162.00K derived: sum of 3 quarters · filed 2021-03-11 | $165.00K 10-K · filed 2021-03-11 |
| 2019-09-28 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $181.00K derived: sum of 2 quarters · filed 2020-08-07 | $184.00K 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $151.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $3.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $418.00K 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $284.00K 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $40.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $40.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |